The Board of Directors of Nigeria LNG Limited (NLNG) has approved the appointment of Dr. Philip Mshelbila as successor to Engr. Tony Attah, Managing Director and Chief Executive Officer.
Engr. Attah will return to his parent company, Shell, on 30th August 2021 at the expiration of his five-year tenure at the helm of affairs. Engr. Attah was appointed Chief Executive Officer by the NLNG Board in July 2016.
Dr. Mshelbila, who is rounding-up his tenure as Chief Executive Officer, Atlantic LNG Company of Trinidad & Tobago, will be taking over from Engr. Attah on 31st August 2021.
As NLNG flags off Train 7 Project
Buhari flags off NLNG Train 7, targets $10bn investments
NLNG is an incorporated Joint-Venture owned by four Shareholders, namely, the Federal Government of Nigeria, represented by Nigerian National Petroleum Corporation (49%), Shell Gas B.V. (25.6%), Total Gaz Electricite Holdings France (15%), and Eni International N.A. N.V. S.àr.l (10.4%).
Dr Mshelbila is currently the CEO for Atlantic LNG Company of Tinidad & Tobago. Prior to this he was the General Manager, Gas for Shell Nigeria and a director of the Shell Petroleum Development Company of Nigeria Ltd (SPDC). Before that, he held the positions of Regional Communications Manager for Shell in West Africa and General Manager for Sustainable Development and Community Relations for Shell Nigeria.
Prior to that he was the Managing Director of Shell Nigeria Gas Ltd and Crisis Chief of Staff for Shell Nigeria. In the course of his 25 year career with Shell, he has held various roles including Integration/Planning and Project Development Manager for Gas & Power, Commercial Manager, Private Assistant to the Chief Executive of Royal Dutch Shell in The Netherlands, Regional (Business) Adviser for Africa – Shell International and Regional Health Manager for Africa overseeing 36 countries. Prior to joining Shell, he worked with the Nigerian National Petroleum Corporation (NNPC) and National Oil & Chemical Marketing Company Plc (NOLCHEM).
Dr. Mshelbila has a degree in Human Medicine (MBBS), postgraduate qualification in Occupational & Environmental Medicine from the University of Aberdeen, Scotland and a Masters of Business Administration (MBA) degree from the IESE Business School of the University of Navarra, Spain.
